FDA clears new AI-powered MRI system from Fujifilm
The U.S. Food and Drug Administration has cleared a new magnetic resonance imaging system from Fujifilm, the company announced on Wednesday.
The Echelon Synergy MRI machine utilizes proprietary deep learning reconstruction technology to enhance sharpness and acquire images faster. Fujifilm Healthcare Americas Corp., which is based in Lexington, Massachusetts, believes the product can help providers bolster both throughput and customer satisfaction.
“Echelon Synergy is designed to facilitate optimal comfort and help alleviate anxiety with its large bore and wide patient table,” Shawn Etheridge, executive director of modality solutions, said in an Aug. 23 announcement. “Alleviating any patient anxiety not only helps to enhance the patient experience, but could also improve a radiologist’s workflow, as the less nervous a patient, the more efficient and quickly the scan will get done.”
In addition, the system also offers a one-touch workflow for brain and knee imaging, automatically positioning patients and starting the scan once the exam room door is closed.
Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic.